Bob

Progress and Challenges in the Fight against Hepatitis B and C in Uzbekistan: A Path toward Elimination by 2030

Erkin MusabaevThe Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Centre for Epidemiology, Microbiology, Infectious, and Parasitic Diseases , Tashkent , UzbekistanL. N. TuychievThe Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Centre for Epidemiology, Microbiology, Infectious, and Parasitic Diseases , Tashkent , UzbekistanShakhlo SadirovaCenter for Disease Analysis Foundation , Lafayette , USAShakhista BakievaThe Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Centre for Epidemiology, Microbiology, Infectious, and Parasitic Diseases , Tashkent , UzbekistanUmed IsmailovThe Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Centre for Epidemiology, Microbiology, Infectious, and Parasitic Diseases , Tashkent , UzbekistanBakhodir YusupaliyevSanitary-Epidemiological Welfare and Public Health Committee under the Ministry Health of the Republic of Uzbekistan , Tashkent , UzbekistanRafail IbragimovSanitary-Epidemiological Welfare and Public Health Committee under the Ministry Health of the Republic of Uzbekistan , Tashkent , UzbekistanMalika KhodjaevaPublic Health and Management Department , Tashkent State Medical University , UzbekistanNargiz IbadullaevaThe Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Centre for Epidemiology, Microbiology, Infectious, and Parasitic Diseases , Tashkent , Uzbekistan

2025en

Ochiq kirishGibrid

Litsenziya: cc-by

ABI

Annotatsiya

This paper presents a comprehensive review of Uzbekistan’s national response to hepatitis B and C, outlining progress, challenges, and opportunities for elimination by 2030. Drawing on population-based serological surveys, program implementation data, and international cooperation frameworks, the study identifies persistent gaps in screening coverage, public awareness, access to diagnostics and treatment, and health system infrastructure. The paper highlights successful strategies such as catalytic funding, international drug donations, and simplified care pathways. Recommendations include expanding targeted screening, integrating digital stock management systems, and strengthening laboratory and research capacity. With continued governmental commitment and global support, Uzbekistan is on a path to achieving hepatitis elimination as a public health threat.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.5772/intechopen.115660

Iqtiboslar va manbalar

0 ta iqtibos3 ta foydalanilgan manba